Finanztrends
Deine Einschätzung
Was spricht für und gegen Advanced Proteome Therapeutics in den nächsten Jahren?
Pro
?
W******* i* V********
?
A****************
?
M************
Kontra
?
L*********** I********** f** d** n******* J****
?
M****
?
U****************
Sag uns deine Meinung, um die 'Wisdom of the Crowds' zu nutzen
Rendite von Advanced Proteome Therapeutics im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Advanced Proteome Therapeutics | - | - | - | - | - | - | - |
| Larimar Therapeutics Inc. | -2,66 % | -2,82 % | -7,53 % | 9,55 % | 3,61 % | -1,71 % | -62,81 % |
| Northwest Biotherapeutics Inc. | 0,00 % | 36,36 % | 12,50 % | -7,22 % | -12,62 % | -59,64 % | -83,64 % |
| Achieve Life Sciences Inc. | 1,75 % | 4,59 % | 11,76 % | 171,43 % | 54,05 % | 18,75 % | -5,79 % |
News
Candel Therapeutics Eyes 2026 Prostate Cancer Filing as Lung Study Ramps Up
Key Points
- Interested in Candel Therapeutics, Inc.? Here are five stocks we like better.
- Candel Therapeutics plans to submit a biologics license application by the end of 2026 for aglatimagene
The $1.3 Trillion Inference War Is Heating Up. 3 Stocks to Watch.
Inference has become the fastest-growing part of the artificial intelligence (AI) infrastructure market, and Bloomberg Intelligence projects it will double the size of the AI training market by
Spectral AI Q2 Earnings Call Highlights
Key Points
- Interested in Spectral AI, Inc.? Here are five stocks we like better.
- FDA clearance is shifting Spectral AI toward commercialization: The company plans a disciplined U.S. and